Amprius Just Lifted Its 2026 Revenue Target-Can It Hold the Rally at $10?

Raised 2026 guidance shifted the burden of proof

Amprius changed the setup last month when it raised its 2026 revenue outlook to at least $130 million while maintaining targets for net loss below $8.0 million and positive non-GAAP Adjusted EBITDA of at least $4.0 million. That moves the discussion past simple product potential and onto execution: can management support a stronger year?

Why this earnings report matters now

Amprius is reporting second-quarter 2026 results on Aug. 5, before the opening bell. The immediate hurdle is straightforward: roughly $29.29 million in revenue and a loss of 2.3 cents per share. With the stock around $10 and a $23 consensus target, this release can either validate the new narrative or expose it as momentum-driven.

One strong quarter is not enough by itself. If revenue comes in clean but margins stall or guidance wobbles, the market can quickly shift from optimism to skepticism.

Q1 growth was clear; margin durability is the real test

After Q1 revenue of $28.5 million and a net loss of $5.0 million versus $9.4 million a year earlier, the demand story no longer needs proving in absolute terms. The harder question is whether that demand is becoming economically durable.

Amprius gave investors a reason to look at margins closely. In Q1, it reported GAAP gross margin of 20%, or 22% excluding Colorado expenses, while gross profit improving 343% YoY. That is the kind of signal investors want during a manufacturing ramp: more units spreading fixed cost and helping narrow losses.

Still, one quarter is not enough to call that trend permanent. Bulls need to see margin hold or improve. Bears can argue that early wins often look cleaner than repeat production, and that lower-volume programs, qualification costs, or a softer shipment mix could slow progress.

Market expectations already show more caution on earnings

Amprius is reporting second-quarter 2026 results on Aug. 5, and the Zacks Consensus Estimate for the top line is pegged at $29.08 million. But the more telling signal is on profitability. EPS estimates have fallen 6.25% over the past 60 days, even as revenue estimates have remained essentially flat over the same period.

That split matters. It suggests analysts are less skeptical of the revenue story than of how quickly growth converts into earnings improvement.

What would confirm or break the rerating

The core question is simple: does this report give investors a reason to keep underwriting the new year? A print above expectations helps, but the bigger test is whether management can still support its 2026 revenue outlook to at least $130 million, along with its net loss below $8.0 million and positive non-GAAP Adjusted EBITDA of at least $4.0 million.

What confirms the rerating

• Revenue comes in above the current bar.
• The loss narrows cleanly from Q1.
• Management keeps the raised full-year framework intact.

What breaks it

• Revenue is merely adequate while the loss narrows more slowly than expected.
• Gross margin slips from Q1 levels.
• Commentary suggests the raised 2026 targets are under pressure.

What to watch over the next few quarters

• Whether revenue can hold above the Q2 consensus Estimate is pegged at $29.08 million.
• Whether gross margin remains near the GAAP gross margin of 20% shown in Q1.
• Whether the company stays on track for positive non-GAAP Adjusted EBITDA of at least $4.0 million.

If Amprius beats, holds margin, and preserves its full-year frame, the rerating can extend. If margin slips or guidance wobbles, the same momentum that helped the stock can work against it.